您的位置: 首页 > 农业专利 > 详情页

Pharmaceutical compositions comprising inhibitors of zinc-ZIP8-MTF1 as active ingredients for preventing or treating a joint disease
专利权人:
GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
发明人:
Jang-Soo Chun,Jin-Hong Kim
申请号:
US14595150
公开号:
US09526782B2
申请日:
2015.01.12
申请国别(地区):
US
年份:
2016
代理人:
摘要:
The present invention relates to identification of Zinc-ZIP8-MTF1 axis that plays an important role to OA (osteoarthritis) pathogenesis process and a novel use thereof. According to the present invention, ZIP8 and MTF1 of the present invention increase in the expression in joint disease induced cells or cartilage tissue, and induce the expression of various matrix-degrading enzymes (e.g., MMP-3, MMP-9, MMP-12, MMP-13 and ADAMTS-5 etc.). In addition, when the expression of ZIP8 or MTF1 is inhibited in cells or tissues of animals (e.g., human, mouse), OA pathogenesis is inhibited. Therefore, the ZIP8 and MTF1 of the present invention may be applied to the diagnosis or prognosis of joint diseases, and may be used for the development of therapeutics for joint diseases using these.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充